SCHEMBL21172502

SCHEMBL21172502

CCOC(=O)c1ccc2c(c1)CC(C)[C@H](C)N2C(C)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 1/20 0.45
SRD5A2 P31213 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 5/20 0.43
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA7 P43166 2/20 0.43
CA9 Q16790 2/20 0.43
CA14 Q9ULX7 2/20 0.43
TP53 P04637 1/20 0.41
PRMT1 Q99873 1/20 0.41
HPGD P15428 3/20 0.41
LMNA P02545 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPK1 P28482 1/20 0.40
KDM4E B2RXH2 1/20 0.39
HSD17B2 P37059 1/20 0.39
MAPT P10636 2/20 0.39
ESR1 P03372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24347596 1.00 SRD5A1 (0.45) SRD5A1SRD5A2SMN1; SMN2ALDH1A1CA12
SCHEMBL24347185 0.89 SRD5A1 (0.44) SRD5A1SRD5A2SMN1; SMN2ALDH1A1CA12
SCHEMBL24347614 0.88 SRD5A1 (0.43) SRD5A1SRD5A2SMN1; SMN2ALDH1A1CA12
SCHEMBL21173162 0.88 SRD5A1 (0.43) SRD5A1SRD5A2SMN1; SMN2ALDH1A1CA12
SCHEMBL21172626 0.88 SRD5A1 (0.43) SRD5A1SRD5A2SMN1; SMN2ALDH1A1CA12
SCHEMBL21172631 0.86 TP53 (0.43) SRD5A1SRD5A2SMN1; SMN2ALDH1A1CA12
SCHEMBL21172578 0.86 TP53 (0.43) SRD5A1SRD5A2SMN1; SMN2ALDH1A1CA12
SCHEMBL21172581 0.82 TDP1 (0.44) ALDH1A1HPGDKDM4EMAPTESR1
SCHEMBL21172885 0.82 TDP1 (0.44) ALDH1A1HPGDKDM4EMAPTESR1
SCHEMBL21173173 0.81 KMT2A (0.45) SMN1; SMN2ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3511323-B1 2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE IP NO 2 LTD (GB) 2022-03-02 EP disclosed
EP-3511323-A1 2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS GlaxoSmithKline Intellectual Property (No.2) Limited (GB) 2019-07-17 EP disclosed